Healthy adults
Conditions
Interventions
Take 2 tablets the test food once a day with water or warm water after breakfast.
Take 2 tablets a placebo food once a day with water or warm water after breakfast.
Sponsors
IMEQRD Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged between 30 and 70 years. 2. Japanese male or female. 3. Those who are susceptible to upper respiratory disease. 4. Those who can use smartphones or PCs to input an electronic diary. 5. Those who received sufficient explanation about the trial, volunteered to participate after understanding the purpose, and agree to participate in the trial with written consent.
Exclusion criteria
Exclusion criteria: 1. Those who are currently undergoing treatment for any disease. Also, those who receive medical treatments from medical doctors via drugs or traditional Chinese medicines. 2. Those who receive diet or exercise therapies by doctors. 3. Those who have severe diseases or history of severe diseases. 4. Those who have allergic dermatitis, allergic rhinitis, bronchial asthma, and chronic bronchitis. 5. Those who have currently been taking drugs, quasi-drug products, and foods or supplements which have health claims. However, those who can discontinue taking these materials during the trial period after obtaining informed consent will be allowed to join the trial. 6. Those who have currently been taking yogurts or beverages, which include Lactobacillus and/or Bifidobacterium for being healthy. However, those who can discontinue taking these foods during the trial period after obtaining informed consent will be allowed to join the trial. 7. Those who received the vaccination against SARS-CoV2 after May 2021. Also, those who receive the vaccination during the trial period. 8. Those who have a drug allergy or a food allergy. 9. Those who work on the night shift and the shiftwork. 10. Heavy drinkers who drink over 60 g alcohol/day. 11. Those who have a smoking habit (over 21 cigarettes/day). 12. Those who are planning extremely change their lifestyle (such as diet, sleep, or exercise) during the trial period. 13. Those who are currently pregnant or breastfeeding, or those who are planning to pregnant during the trial period. 14. Those who are planning travels to foreign countries during the trial period. 15. Those who joined other clinical trials from 1 month before obtaining informed consent in this trial, or those who have currently been joined other clinical trials. Also, those who are planning to join other clinical trials. 16. Those who are unsuitable for this trial that judged by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A subjective questionnaire for physical condition | — |
Secondary
| Measure | Time frame |
|---|---|
| Immune markers (TNFa, IFNg, IL6, IL4 and IL1b levels in blood, and cytotoxic activity of NK cells) | — |
Countries
Japan
Contacts
Public ContactHirokuni Kayama
IMEQRD Co., Ltd. Planning and Sales Department
Outcome results
None listed